In 2010, an attorney jumped in front of a train and his widow claims his suicide should be blamed on GlaxoSmithKline for failing to update the warnings on its Paxil antidepressant.

So Wendy Dolin later filed a lawsuit seeking $12 million on the grounds that the drug maker knew its pill puts adults at risk for suicide. Yet her husband had taken a generic version of the drug at the time he committed suicide, and this is one of a few intriguing elements in a closely watched case that is under way in a Chicago federal courtroom.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy